TSCM yields 11.13% · JNJ yields 2.14%● Live data
📍 TSCM pulled ahead of the other in Year 1
Combined, TSCM + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TSCM + JNJ for your $10,000?
TSCM an actively managed ETF focused on investing in a high conviction portfolio of mid-cap US companies that demonstrate strong growth and profitability characteristics, as defined by factors such as sales and earnings growth and efficient earnings generation. The portfolio managers, use a bottom-up, research driven process to identify and select these quality growth companies, continuously monitoring and re-optimizing the portfolio while considering fundamental and risk factors. Securities are sold if price targets are met or if the company no longer meets operational or growth standards. The portfolio may include common and preferred stocks, convertible securities, and rights/warrants, and smaller allocations to other assets such as REITs when warranted. The overall aim is to maintain a portfolio with growth and profitability attributes at least equal to those of the Russell Midcap Growth Index.
Full TSCM Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.